| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 KLHL5 MYL2 MYL9 MYO9A MYH14 SYNE1 DIAPH1 ARFGEF1 ROCK1 ACTN4 DLEC1 JAKMIP1 SNAP25 FYN MYL12B NEXN ADD2 | 1.99e-07 | 1099 | 87 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 6.66e-06 | 227 | 87 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 KLHL5 MYL2 MYO9A MYH14 SYNE1 DIAPH1 ACTN4 NEXN ADD2 | 7.32e-06 | 479 | 87 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.22e-05 | 38 | 87 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | myosin binding | 3.49e-05 | 85 | 87 | 5 | GO:0017022 | |
| GeneOntologyMolecularFunction | myosin heavy chain binding | 5.20e-05 | 17 | 87 | 3 | GO:0032036 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.66e-04 | 118 | 87 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 FAT2 TCHH MYL2 MYL9 PKD2L2 PCLO ACTN4 CALML5 MYL12B TBC1D9 | 4.02e-04 | 749 | 87 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 8.69e-04 | 43 | 87 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | profilin binding | 1.42e-03 | 13 | 87 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.65e-03 | 507 | 87 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.65e-03 | 507 | 87 | 8 | GO:0030695 | |
| GeneOntologyCellularComponent | myosin complex | 4.11e-09 | 59 | 85 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYL2 MYL9 MYO9A MYH14 ARHGEF5 DIAPH1 ACTN4 LRRC7 SNAP25 FYN MYL12B NEXN ADD2 | 1.02e-08 | 576 | 85 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | myosin II complex | 9.01e-08 | 28 | 85 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 COL6A3 MYH4 MYL2 MYL9 CFAP77 MYO9A MYH14 SYNE1 GRAMD2B DIAPH1 ACTN4 JAKMIP1 FYN MYL12B NEXN DNAH1 | 4.39e-06 | 1179 | 85 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 COL6A3 MYH4 MYL2 MYL9 CFAP77 MYO9A MYH14 SYNE1 GRAMD2B DIAPH1 ACTN4 JAKMIP1 FYN MYL12B NEXN DNAH1 | 4.81e-06 | 1187 | 85 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TSNAXIP1 BPTF PDE4A PDE4C SYNE1 PCLO CEP250 ARFGEF1 DEPDC5 ACTN4 SNAP25 FYN GOLGA1 TP53BP2 EPG5 | 4.85e-06 | 934 | 85 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | sarcomere | 7.91e-06 | 249 | 85 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.54e-05 | 273 | 85 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.38e-05 | 290 | 85 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.50e-05 | 16 | 85 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.40e-04 | 25 | 85 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 9.56e-04 | 107 | 85 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 9.56e-04 | 107 | 85 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 1.33e-03 | 117 | 85 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.37e-03 | 118 | 85 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | ruffle | 1.53e-03 | 206 | 85 | 5 | GO:0001726 | |
| MousePheno | abnormal podocyte adhesion | 2.69e-05 | 2 | 73 | 2 | MP:0011864 | |
| Domain | EF_HAND_2 | 1.06e-06 | 231 | 85 | 9 | PS50222 | |
| Domain | - | 2.89e-06 | 261 | 85 | 9 | 1.10.238.10 | |
| Domain | EF_HAND_1 | 4.14e-06 | 204 | 85 | 8 | PS00018 | |
| Domain | EF-hand_1 | 5.97e-06 | 152 | 85 | 7 | PF00036 | |
| Domain | EF-hand-dom_pair | 6.25e-06 | 287 | 85 | 9 | IPR011992 | |
| Domain | EF_hand_dom | 1.06e-05 | 232 | 85 | 8 | IPR002048 | |
| Domain | EF_Hand_1_Ca_BS | 1.50e-05 | 175 | 85 | 7 | IPR018247 | |
| Domain | ARHGEF5_35 | 2.05e-05 | 2 | 85 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 2.05e-05 | 2 | 85 | 2 | IPR029212 | |
| Domain | EF-hand_6 | 2.52e-05 | 13 | 85 | 3 | PF13405 | |
| Domain | Myosin_head_motor_dom | 2.62e-05 | 38 | 85 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.62e-05 | 38 | 85 | 4 | PS51456 | |
| Domain | Myosin_head | 2.62e-05 | 38 | 85 | 4 | PF00063 | |
| Domain | MYSc | 2.62e-05 | 38 | 85 | 4 | SM00242 | |
| Domain | Myosin_N | 3.98e-05 | 15 | 85 | 3 | PF02736 | |
| Domain | Myosin_N | 3.98e-05 | 15 | 85 | 3 | IPR004009 | |
| Domain | Myosin_tail_1 | 7.07e-05 | 18 | 85 | 3 | PF01576 | |
| Domain | Myosin_tail | 7.07e-05 | 18 | 85 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 8.36e-05 | 19 | 85 | 3 | IPR027401 | |
| Domain | - | 8.36e-05 | 19 | 85 | 3 | 4.10.270.10 | |
| Domain | EFh | 8.40e-05 | 158 | 85 | 6 | SM00054 | |
| Domain | IQ | 3.08e-04 | 71 | 85 | 4 | PF00612 | |
| Domain | IQ | 5.09e-04 | 81 | 85 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 7.58e-04 | 90 | 85 | 4 | IPR000048 | |
| Domain | IQ | 8.57e-04 | 93 | 85 | 4 | PS50096 | |
| Domain | GRAM | 2.36e-03 | 16 | 85 | 2 | SM00568 | |
| Domain | Post-SET_dom | 2.36e-03 | 16 | 85 | 2 | IPR003616 | |
| Domain | PostSET | 2.36e-03 | 16 | 85 | 2 | SM00508 | |
| Domain | POST_SET | 2.36e-03 | 16 | 85 | 2 | PS50868 | |
| Domain | PDEase | 3.33e-03 | 19 | 85 | 2 | IPR023088 | |
| Domain | RCC1 | 3.69e-03 | 20 | 85 | 2 | PF00415 | |
| Domain | PDEase_I | 4.06e-03 | 21 | 85 | 2 | PF00233 | |
| Domain | RCC1_1 | 4.06e-03 | 21 | 85 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.06e-03 | 21 | 85 | 2 | PS00626 | |
| Domain | RCC1_3 | 4.06e-03 | 21 | 85 | 2 | PS50012 | |
| Domain | PDEASE_I | 4.06e-03 | 21 | 85 | 2 | PS00126 | |
| Domain | PDEase_CS | 4.06e-03 | 21 | 85 | 2 | IPR023174 | |
| Domain | Reg_chr_condens | 4.46e-03 | 22 | 85 | 2 | IPR000408 | |
| Domain | GRAM | 4.46e-03 | 22 | 85 | 2 | PF02893 | |
| Domain | GRAM | 4.46e-03 | 22 | 85 | 2 | IPR004182 | |
| Domain | - | 4.46e-03 | 22 | 85 | 2 | 2.130.10.30 | |
| Domain | - | 4.46e-03 | 22 | 85 | 2 | 1.10.1300.10 | |
| Domain | Znf_FYVE_PHD | 4.55e-03 | 147 | 85 | 4 | IPR011011 | |
| Domain | PHD | 4.85e-03 | 75 | 85 | 3 | PF00628 | |
| Domain | Actinin_actin-bd_CS | 4.87e-03 | 23 | 85 | 2 | IPR001589 | |
| Domain | Spectrin | 4.87e-03 | 23 | 85 | 2 | PF00435 | |
| Domain | PDEase_catalytic_dom | 4.87e-03 | 23 | 85 | 2 | IPR002073 | |
| Domain | ACTININ_2 | 4.87e-03 | 23 | 85 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.87e-03 | 23 | 85 | 2 | PS00019 | |
| Domain | RCC1/BLIP-II | 4.87e-03 | 23 | 85 | 2 | IPR009091 | |
| Domain | HDc | 5.29e-03 | 24 | 85 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 5.29e-03 | 24 | 85 | 2 | IPR003607 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.79e-07 | 11 | 70 | 4 | M47721 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.77e-07 | 132 | 70 | 8 | M11355 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.83e-07 | 29 | 70 | 5 | M27309 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 2.04e-06 | 19 | 70 | 4 | M6355 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.04e-06 | 19 | 70 | 4 | M27493 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.54e-06 | 20 | 70 | 4 | M18415 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 3.13e-06 | 21 | 70 | 4 | MM1390 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 3.13e-06 | 21 | 70 | 4 | M1001 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 5.50e-06 | 24 | 70 | 4 | M2243 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.11e-06 | 199 | 70 | 8 | M7253 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY | 1.37e-05 | 10 | 70 | 3 | M47739 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.59e-05 | 64 | 70 | 5 | M7923 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.29e-05 | 69 | 70 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.46e-05 | 70 | 70 | 5 | M41806 | |
| Pathway | WP_FOCAL_ADHESION | 5.68e-05 | 199 | 70 | 7 | M39402 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 8.72e-05 | 213 | 70 | 7 | M18306 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 9.19e-05 | 92 | 70 | 5 | M27201 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.07e-04 | 19 | 70 | 3 | M27489 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 1.26e-04 | 20 | 70 | 3 | MM1476 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.46e-04 | 21 | 70 | 3 | M27494 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 1.93e-04 | 23 | 70 | 3 | M46455 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.93e-04 | 23 | 70 | 3 | MM15222 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 2.73e-04 | 116 | 70 | 5 | M2164 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.99e-04 | 70 | 70 | 4 | MM15597 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.99e-04 | 70 | 70 | 4 | M12294 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 4.94e-04 | 74 | 70 | 4 | M41807 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 6.85e-04 | 35 | 70 | 3 | MM15114 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 6.92e-04 | 142 | 70 | 5 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 8.59e-04 | 149 | 70 | 5 | M41805 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 8.73e-04 | 38 | 70 | 3 | M39549 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 1.09e-03 | 41 | 70 | 3 | M232 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CKB MYL9 MYO9A MYH14 ARHGEF5 DIAPH1 NUP43 ROCK1 CAVIN1 MYL12B | 1.30e-03 | 649 | 70 | 10 | MM15690 |
| Pathway | PID_RHOA_PATHWAY | 1.43e-03 | 45 | 70 | 3 | M12 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.71e-03 | 257 | 70 | 6 | MM14755 | |
| Pubmed | KMT2D EVC2 CEP250 ASH1L USP25 DIAPH1 ROCK1 HERC2 HERC1 TP53BP2 EPG5 | 3.43e-07 | 591 | 89 | 11 | 15231748 | |
| Pubmed | MYH14 CPSF6 ACTN4 HSPBP1 USP54 FYN CNTROB TRIM22 GPAT4 CCDC136 TP53BP2 | 4.54e-07 | 608 | 89 | 11 | 16713569 | |
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 8207020 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 1.92e-06 | 10 | 89 | 3 | 24825879 | |
| Pubmed | 2.46e-06 | 234 | 89 | 7 | 36243803 | ||
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 9171826 | ||
| Pubmed | CKB TET2 BPTF KMT2D MYH14 TNIP2 SMCHD1 G3BP2 RLIM RBM6 USP54 HERC2 HERC1 CALML5 ARID3B | 3.27e-06 | 1429 | 89 | 15 | 35140242 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 4.40e-06 | 621 | 89 | 10 | 22794259 | |
| Pubmed | TET2 STX18 MYH14 MTIF2 SYNE1 ASH1L USP25 NUP43 DLST ACTN4 JAKMIP1 SNAP25 USP54 HERC2 | 4.73e-06 | 1285 | 89 | 14 | 35914814 | |
| Pubmed | 5.26e-06 | 496 | 89 | 9 | 31343991 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYL9 MYH14 CPSF6 SYNE1 G3BP2 RIOX1 ACTN4 CAVIN1 RIOK2 FYN MYL12B NEXN | 5.49e-06 | 949 | 89 | 12 | 36574265 |
| Pubmed | 5.51e-06 | 45 | 89 | 4 | 22114352 | ||
| Pubmed | ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. | 6.48e-06 | 2 | 89 | 2 | 12021256 | |
| Pubmed | ROCK and Dia have opposing effects on adherens junctions downstream of Rho. | 6.48e-06 | 2 | 89 | 2 | 11992112 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23732111 | ||
| Pubmed | Interaction of the SH2 domain of Fyn with a cytoskeletal protein, beta-adducin. | 6.48e-06 | 2 | 89 | 2 | 11526103 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23043089 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 6.48e-06 | 2 | 89 | 2 | 9382868 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 11150240 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 31311407 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 6.48e-06 | 2 | 89 | 2 | 11744674 | |
| Pubmed | 8.86e-06 | 16 | 89 | 3 | 16494860 | ||
| Pubmed | GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. | 8.86e-06 | 16 | 89 | 3 | 9136932 | |
| Pubmed | 8.86e-06 | 16 | 89 | 3 | 19794400 | ||
| Pubmed | COL6A3 STX18 TUT7 GRAMD2B ASH1L DLST RIOX1 USP54 HERC2 MYL12B CNTROB TBC1D9 ADD2 | 1.30e-05 | 1215 | 89 | 13 | 15146197 | |
| Pubmed | 1.51e-05 | 430 | 89 | 8 | 32581705 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CKB GUCY1B2 MYH14 CPSF6 SYNE1 SMCHD1 G3BP2 PCLO DIAPH1 POLRMT DLST ACTN4 HSPBP1 CALML5 | 1.52e-05 | 1425 | 89 | 14 | 30948266 |
| Pubmed | ANKRD35 GALE CCDC9B MYH14 CPSF6 G3BP2 DIAPH1 RIOX1 ACTN4 FYN MYL12B TP53BP2 DNAH1 | 1.70e-05 | 1247 | 89 | 13 | 27684187 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.78e-05 | 440 | 89 | 8 | 34244565 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.82e-05 | 580 | 89 | 9 | 35676659 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.94e-05 | 3 | 89 | 2 | 26059207 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 36515178 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 28191820 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 27880913 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17244674 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 26881253 | ||
| Pubmed | The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. | 1.94e-05 | 3 | 89 | 2 | 26551667 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 23188716 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 11942626 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 25660448 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH14 MTIF2 G3BP2 CEP250 TUT7 USP25 JAKMIP1 USP54 HERC2 GPAT4 | 2.35e-05 | 754 | 89 | 10 | 33060197 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CKB STX18 CPSF6 TNIP2 SMCHD1 DLST ACTN4 HSPBP1 HERC2 CALML5 TBC1D9 | 2.38e-05 | 922 | 89 | 11 | 27609421 |
| Pubmed | 2.55e-05 | 225 | 89 | 6 | 25277244 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CKB STX18 SDHAF3 CPSF6 MTIF2 SYNE1 G3BP2 PCLO TUT7 POLRMT DLST HERC2 HERC1 GPAT4 | 2.60e-05 | 1496 | 89 | 14 | 32877691 |
| Pubmed | 2.71e-05 | 67 | 89 | 4 | 29735542 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 2.95e-05 | 231 | 89 | 6 | 36597993 | |
| Pubmed | 3.10e-05 | 233 | 89 | 6 | 29518331 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.25e-05 | 235 | 89 | 6 | 28378594 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 3.31e-05 | 626 | 89 | 9 | 33644029 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 10388558 | ||
| Pubmed | Association analysis of podocyte slit diaphragm genes as candidates for diabetic nephropathy. | 3.87e-05 | 4 | 89 | 2 | 17968527 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19265163 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 9371714 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 24732776 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 11023856 | ||
| Pubmed | Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice. | 3.87e-05 | 4 | 89 | 2 | 34943270 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19900187 | ||
| Pubmed | BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity. | 3.87e-05 | 4 | 89 | 2 | 15644318 | |
| Pubmed | PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice. | 3.87e-05 | 4 | 89 | 2 | 32738081 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 1985022 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 8413254 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 37801199 | ||
| Pubmed | The Trithorax protein Ash1L promotes myoblast fusion by activating Cdon expression. | 3.87e-05 | 4 | 89 | 2 | 30487570 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.87e-05 | 4 | 89 | 2 | 11029314 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 26819309 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 22946044 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 18648664 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 33609559 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 3.87e-05 | 4 | 89 | 2 | 18417546 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 12547197 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 23951055 | ||
| Pubmed | Mouse myosin-19 is a plus-end-directed, high-duty ratio molecular motor. | 3.87e-05 | 4 | 89 | 2 | 24825904 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9A MYH14 SMCHD1 TUT7 DIAPH1 POLRMT DLST ACTN4 CAVIN1 HERC2 RIOK2 NEXN TP53BP2 | 3.97e-05 | 1353 | 89 | 13 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.17e-05 | 807 | 89 | 10 | 30575818 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 4.53e-05 | 27 | 89 | 3 | 23395962 | |
| Pubmed | 4.59e-05 | 653 | 89 | 9 | 22586326 | ||
| Pubmed | 4.59e-05 | 503 | 89 | 8 | 36217030 | ||
| Pubmed | 4.95e-05 | 78 | 89 | 4 | 28611094 | ||
| Pubmed | 6.06e-05 | 844 | 89 | 10 | 25963833 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 6.20e-05 | 264 | 89 | 6 | 32814769 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 11160423 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 6.44e-05 | 5 | 89 | 2 | 30737693 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15096506 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 33944911 | ||
| Pubmed | Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. | 6.44e-05 | 5 | 89 | 2 | 19160018 | |
| Pubmed | Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice. | 6.44e-05 | 5 | 89 | 2 | 29653945 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 6196357 | ||
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 6.44e-05 | 5 | 89 | 2 | 18194650 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 8586960 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 19117032 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 6.44e-05 | 5 | 89 | 2 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 6.44e-05 | 5 | 89 | 2 | 12919077 | |
| Pubmed | 6.91e-05 | 31 | 89 | 3 | 21985497 | ||
| Pubmed | CKB MYO9A MYH14 SYNE1 G3BP2 PCLO DLST ACTN4 LRRC7 USP54 MYL12B ADD2 TP53BP2 | 7.03e-05 | 1431 | 89 | 13 | 37142655 | |
| Pubmed | 7.34e-05 | 538 | 89 | 8 | 28524877 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.50e-05 | 398 | 89 | 7 | 35016035 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 8.36e-05 | 33 | 89 | 3 | 32094117 | |
| Pubmed | 8.79e-05 | 711 | 89 | 9 | 33022573 | ||
| Pubmed | 9.44e-05 | 285 | 89 | 6 | 32838362 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 9.56e-05 | 719 | 89 | 9 | 35337019 | |
| Interaction | PPP1R12A interactions | 1.26e-05 | 322 | 89 | 9 | int:PPP1R12A | |
| Interaction | KIF20A interactions | ANKRD35 MYL9 MYH14 SYNE1 TNIP2 G3BP2 PCLO POLRMT ACTN4 CAVIN1 USP54 HERC2 HERC1 SNAPC4 FYN MYL12B | 1.31e-05 | 1052 | 89 | 16 | int:KIF20A |
| Interaction | MYH14 interactions | 2.06e-05 | 189 | 89 | 7 | int:MYH14 | |
| GeneFamily | EF-hand domain containing | 6.92e-07 | 219 | 61 | 8 | 863 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 1.30e-05 | 14 | 61 | 3 | 657 | |
| GeneFamily | Myosin heavy chains | 1.62e-05 | 15 | 61 | 3 | 1098 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 8.53e-04 | 13 | 61 | 2 | 1146 | |
| GeneFamily | Phosphodiesterases | 2.95e-03 | 24 | 61 | 2 | 681 | |
| GeneFamily | PHD finger proteins | 3.49e-03 | 90 | 61 | 3 | 88 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.53e-10 | 199 | 89 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-07 | 199 | 89 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.51e-07 | 199 | 89 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-06 | 183 | 89 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-06 | 185 | 89 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.01e-06 | 186 | 89 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 188 | 89 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.14e-06 | 188 | 89 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-06 | 188 | 89 | 6 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 189 | 89 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.42e-06 | 192 | 89 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-06 | 200 | 89 | 6 | 2bc7f462a551292de2501028164573935232f899 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.06e-06 | 200 | 89 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-06 | 200 | 89 | 6 | 8b80a65b69b36ed405214564b939452c90aa40d6 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 145 | 89 | 5 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 145 | 89 | 5 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.91e-05 | 163 | 89 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 167 | 89 | 5 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 171 | 89 | 5 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 171 | 89 | 5 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 176 | 89 | 5 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-05 | 177 | 89 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 178 | 89 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-05 | 180 | 89 | 5 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 180 | 89 | 5 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-05 | 188 | 89 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.87e-05 | 189 | 89 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-05 | 190 | 89 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 3.97e-05 | 190 | 89 | 5 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-05 | 191 | 89 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-05 | 191 | 89 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 192 | 89 | 5 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.27e-05 | 193 | 89 | 5 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.27e-05 | 193 | 89 | 5 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.27e-05 | 193 | 89 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-05 | 194 | 89 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.38e-05 | 194 | 89 | 5 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 194 | 89 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-05 | 194 | 89 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 195 | 89 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.49e-05 | 195 | 89 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 195 | 89 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 4.60e-05 | 196 | 89 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-05 | 196 | 89 | 5 | 20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.60e-05 | 196 | 89 | 5 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 197 | 89 | 5 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.71e-05 | 197 | 89 | 5 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 197 | 89 | 5 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.71e-05 | 197 | 89 | 5 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.71e-05 | 197 | 89 | 5 | 10e72b425a2bcba35e63a5b074d3dedcd49a762e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 197 | 89 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.83e-05 | 198 | 89 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.83e-05 | 198 | 89 | 5 | 076c862f2a723f0361749377561cae902068b1a0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-05 | 198 | 89 | 5 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.83e-05 | 198 | 89 | 5 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.83e-05 | 198 | 89 | 5 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.94e-05 | 199 | 89 | 5 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.94e-05 | 199 | 89 | 5 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.94e-05 | 199 | 89 | 5 | 1029f3458b7fda464aa0e7ef06e081e2618c1388 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.94e-05 | 199 | 89 | 5 | 8a04398653a1794921d73a6a950c1fb6fdf68c85 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 5f0f67958c9635db53e61f8370a92da6ea3e80fe | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 200 | 89 | 5 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.06e-05 | 200 | 89 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 200 | 89 | 5 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-05 | 200 | 89 | 5 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.06e-05 | 200 | 89 | 5 | 7c8a5465b478f430495942151c36020023d9bac9 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 5.06e-05 | 200 | 89 | 5 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.06e-05 | 200 | 89 | 5 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | distal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.06e-05 | 200 | 89 | 5 | ff64454a08ae8d4cc6e8f0392558460020844bbc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.06e-05 | 200 | 89 | 5 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.06e-05 | 200 | 89 | 5 | ccd0edd483728279fe15d64be3a39e8636bf2eeb | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.06e-05 | 200 | 89 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.06e-05 | 200 | 89 | 5 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | cedbc47b1defb5973cf7ab6baaa2d6f2fd481f88 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | 6f7ff0533339fcc9d316f2c77334a79c1409ec4f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 200 | 89 | 5 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.65e-05 | 116 | 89 | 4 | 1bfd3b0ec4cb5a04c6dfe7861a544eb277e473a3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.65e-05 | 116 | 89 | 4 | a3dcd18807d14e207438f321be62797384fd3907 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.65e-05 | 116 | 89 | 4 | 685484ea4cbefb5aff5f0cd999fdfadc5a5676e1 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.05e-04 | 122 | 89 | 4 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.55e-04 | 135 | 89 | 4 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.55e-04 | 135 | 89 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.60e-04 | 136 | 89 | 4 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.15e-04 | 147 | 89 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.27e-06 | 49 | 54 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | NSC339663 | MYH1 MYH4 MYL2 MYL9 MYO9A MYH14 SYNE1 ROCK1 ACTN4 CAVIN1 SNAP25 MYL12B | 2.32e-10 | 250 | 88 | 12 | CID000003892 |
| Drug | formycin triphosphate | 1.02e-09 | 51 | 88 | 7 | CID000122274 | |
| Drug | purealin | 2.59e-09 | 58 | 88 | 7 | CID006419303 | |
| Drug | blebbistatin | 1.63e-08 | 116 | 88 | 8 | CID003476986 | |
| Drug | B0683 | 1.74e-08 | 117 | 88 | 8 | CID006398969 | |
| Drug | S-(-)-Etomoxir | 1.21e-07 | 100 | 88 | 7 | CID000060765 | |
| Drug | fast white | 5.84e-07 | 42 | 88 | 5 | CID000024008 | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; HL60; HG-U133A | 9.69e-07 | 197 | 88 | 8 | 1717_DN | |
| Drug | clenbuterol | 1.32e-06 | 142 | 88 | 7 | CID000002783 | |
| Drug | eye gene | 1.63e-06 | 369 | 88 | 10 | CID000004782 | |
| Drug | AC1L1IZ2 | 2.72e-06 | 304 | 88 | 9 | CID000004795 | |
| Drug | NSC107658 | 2.87e-06 | 306 | 88 | 9 | CID000002919 | |
| Drug | N-ethylmaleimide | CKB MYH1 MYH4 MYL2 MYL9 STX18 MYO9A MYH14 MTIF2 SNAP25 MYL12B | 4.40e-06 | 511 | 88 | 11 | CID000004362 |
| Drug | oxovanadium | 7.20e-06 | 120 | 88 | 6 | CID000024411 | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.00e-05 | 193 | 88 | 7 | 3086_UP | |
| Drug | AC1NSVQS | 1.20e-05 | 12 | 88 | 3 | CID005317517 | |
| Drug | MAPTAM | 1.25e-05 | 37 | 88 | 4 | CID000123719 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 1.55e-05 | 39 | 88 | 4 | CID000107855 | |
| Drug | hydroxystearic acid | 2.08e-05 | 42 | 88 | 4 | CID000007789 | |
| Drug | SM-2 | 2.21e-05 | 87 | 88 | 5 | CID000486033 | |
| Drug | trifluoperazine | 3.69e-05 | 324 | 88 | 8 | CID000005566 | |
| Drug | 1 SA | 6.06e-05 | 20 | 88 | 3 | CID011987857 | |
| Drug | K-Cl | 6.70e-05 | 567 | 88 | 10 | CID000004873 | |
| Drug | MgCl2 | 6.88e-05 | 354 | 88 | 8 | CID000024584 | |
| Drug | AC1NAQNU | 7.06e-05 | 21 | 88 | 3 | CID004456135 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 8.53e-05 | 186 | 88 | 6 | 7499_UP | |
| Drug | aescine | 8.61e-05 | 60 | 88 | 4 | CID004555259 | |
| Drug | Piclamilast | 8.82e-05 | 4 | 88 | 2 | DB01791 | |
| Drug | arachidonic acid sodium salt; Down 200; 10uM; MCF7; HG-U133A | 1.17e-04 | 197 | 88 | 6 | 441_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 7151_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 2302_UP | |
| Drug | 4-chloroaniline | 1.34e-04 | 202 | 88 | 6 | CID000007812 | |
| Drug | Ibudilast | 1.47e-04 | 5 | 88 | 2 | DB05266 | |
| Drug | 1,7-naphthyridine | 1.47e-04 | 5 | 88 | 2 | CID000009209 | |
| Drug | AC1LADJ6 | 1.51e-04 | 130 | 88 | 5 | CID000486032 | |
| Drug | caged ATP | 1.57e-04 | 70 | 88 | 4 | CID000123806 | |
| Disease | Malignant neoplasm of breast | MYH1 KMT2D SYNE1 G3BP2 EFCAB13 LRRC7 CAVIN1 DLEC1 USP54 HERC2 TP53BP2 EPG5 | 7.30e-05 | 1074 | 87 | 12 | C0006142 |
| Disease | familial hypertrophic cardiomyopathy (is_implicated_in) | 3.05e-04 | 9 | 87 | 2 | DOID:0080326 (is_implicated_in) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Peripheral T-Cell Lymphoma | 3.81e-04 | 10 | 87 | 2 | C0079774 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.56e-04 | 13 | 87 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | coronary artery disease | CKB TET2 COL6A3 MYL2 EFCAB13 LRRC7 CAVIN1 DLEC1 JAKMIP1 FYN EPG5 | 7.63e-04 | 1194 | 87 | 11 | EFO_0001645 |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.80e-04 | 15 | 87 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.11e-03 | 702 | 87 | 8 | C0009402 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.14e-03 | 17 | 87 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.42e-03 | 19 | 87 | 2 | C0751884 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 1.91e-03 | 22 | 87 | 2 | cv:C0949658 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 1.91e-03 | 766 | 87 | 8 | EFO_0004713, GO_0097366 | |
| Disease | Intellectual Disability | 2.10e-03 | 447 | 87 | 6 | C3714756 | |
| Disease | response to radiation | 2.27e-03 | 88 | 87 | 3 | GO_0009314 | |
| Disease | Squamous cell carcinoma of esophagus | 2.82e-03 | 95 | 87 | 3 | C0279626 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 2.88e-03 | 27 | 87 | 2 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | hair shape measurement | 2.88e-03 | 27 | 87 | 2 | EFO_0007824 | |
| Disease | Sezary Syndrome | 2.88e-03 | 27 | 87 | 2 | C0036920 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.88e-03 | 27 | 87 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DAREKQGQQMREAQF | 26 | Q8IVW6 | |
| QMAQARRTNVDEDFI | 781 | Q9HCE0 | |
| GEVVSEQEFRNRMIE | 2176 | Q9NR48 | |
| GEVAQDMQRERRIFQ | 176 | Q8TDY4 | |
| ENERLGVVRDSMFQN | 46 | Q6ZQR2 | |
| TQAQLEERQAEMEGA | 71 | Q6NZI2 | |
| EERQAEMEGAVQSIQ | 76 | Q6NZI2 | |
| AVDFDVRVDTQDQGM | 1656 | Q9Y6D6 | |
| QEQVQDVMLGRQGER | 276 | Q12774 | |
| VENDRQGEAEFNRIM | 801 | O43707 | |
| QEQVQDVMLGRQGER | 276 | A5YM69 | |
| AQAAEQERQASEMRG | 886 | Q8N283 | |
| QERQASEMRGRSEQF | 891 | Q8N283 | |
| EVFERNIRAEGLQME | 136 | Q32M45 | |
| EDMRVQLNVFDEQGE | 356 | O60610 | |
| FINGDVIMEDFNERN | 1591 | Q12830 | |
| AMIREADVDQDGRVN | 121 | Q9NZT1 | |
| VADNERMFDVLQRFG | 56 | Q13625 | |
| NQAMADAFERLGDRQ | 1706 | Q8IZY2 | |
| DVMDLQFFDQERIVA | 76 | Q8NFH3 | |
| DFMNRSGEEQERVLR | 121 | Q96D70 | |
| FEEARRQMVNEDEEN | 281 | Q0ZGT2 | |
| MDQNRDGFIDKNDLR | 36 | P10916 | |
| RDEDGVQMTAQQVFE | 786 | O75140 | |
| RRDEMDELEGFQQQE | 166 | Q92805 | |
| LDEDNMEFQVGDRIV | 696 | P46199 | |
| IEMEQRLEQGQAIDD | 361 | P12277 | |
| EQRQQRMTVAFEFED | 451 | Q96NW7 | |
| EFDEQVAAVREGMAR | 4641 | O95714 | |
| GVEDDQMAQIVERLF | 1971 | Q15751 | |
| EIQEDRRQAEQGGMA | 86 | Q6ZUT6 | |
| RQAQQDRDEMADEVA | 1721 | Q7Z406 | |
| EAFNMIDQNRDGFID | 36 | P24844 | |
| RQEEENGFMQQKGRE | 1976 | Q9Y6V0 | |
| QVRAMDADRGVNAEV | 1576 | Q9NYQ8 | |
| TDRIMAEFFQQGDRE | 606 | P27815 | |
| AEFFQQGDRERERGM | 611 | P27815 | |
| TDRIMAEFFQQGDRE | 561 | Q08493 | |
| ERVQRMEAQEGGFAQ | 951 | Q86UK5 | |
| GVQDQHMDERDVRRF | 276 | Q96N16 | |
| IQGEMEDIIQEARNA | 1741 | P12882 | |
| GQRNVMEVFREEEED | 226 | Q8N8V4 | |
| AAMFTNDVREARQEE | 246 | Q96PQ7 | |
| RVFMEEQRQRQEEEA | 706 | A2A3N6 | |
| VIRNVEAMNFADIER | 331 | P36957 | |
| EFEEMDILDQGALQR | 61 | Q14376 | |
| AQQQRVERFMFEGVE | 1656 | Q9P2D7 | |
| EAEFEEIMNRNRAIS | 411 | Q16630 | |
| MTREADEDAVQFANR | 391 | Q86UL3 | |
| RGDMEQNDSDNRRII | 311 | Q9UN86 | |
| NNREVLEQVERGYRM | 471 | P06241 | |
| EGVNQDTFGRMRDVV | 2411 | P12111 | |
| ELSALRQDMQEAQGE | 1081 | Q9BV73 | |
| SRNENGMVELDDFVN | 501 | Q8IY85 | |
| FSDLDGVVQQRRQDM | 251 | Q96HH9 | |
| QRFRALFEQVAGEDM | 521 | O14815 | |
| ENERVMSQAGVQDLE | 166 | Q9Y238 | |
| NDFRDEQIGQLQELM | 91 | Q9NRP4 | |
| ELQQGQEAARALEDM | 31 | P0C263 | |
| FERRDNMNDNFLEGE | 536 | P05060 | |
| AQVEVFRRQDAQRGM | 961 | O00411 | |
| EMAEREERQQQVAED | 506 | Q8N137 | |
| EAFNMIDQNRDGFID | 36 | O14950 | |
| QEAMSAAFRGQREEV | 76 | Q9NZL4 | |
| QDREHSGMNVNRREE | 301 | P78332 | |
| LNGQEQRMKIDREFA | 546 | A6NHR9 | |
| EEIAGFEDRLNNLQM | 3971 | Q8NF91 | |
| VLEQQRVGFAFDMDE | 906 | Q6P3W6 | |
| LEQQRVGFAVDMDEI | 1151 | Q6P3W6 | |
| EQQRVGFAVDMDEIE | 1396 | Q6P3W6 | |
| RLQDSQGMERDQEAL | 121 | O75343 | |
| IQGEMEDIVQEARNA | 1741 | Q9Y623 | |
| DLDSMLRNEEVQFGQ | 246 | Q9H6W3 | |
| DMGNEIDTQNRQIDR | 166 | P60880 | |
| FNGEMEQEADRINLQ | 261 | P35612 | |
| ELLEDQRRMQEEQGQ | 566 | Q96JN2 | |
| EQLRRQEGGAAEAQM | 76 | Q8NFZ5 | |
| QEGGAAEAQMRQEIE | 81 | Q8NFZ5 | |
| QESQAFQERDGRMVA | 176 | Q86W11 | |
| TERDQIDQDAQIFMR | 91 | Q9P2W9 | |
| EIQMFEQENQRLIGE | 231 | Q9P2W9 | |
| EQIDNLAMRSFGEND | 551 | Q9NVW2 | |
| IAMRQLLDNEGFEQD | 251 | Q6ZT07 | |
| GEDREVNNGLIIMNE | 946 | Q9UHP3 | |
| REGFDENEIQNAEQM | 551 | Q9NZM6 | |
| EFRPFRDEENVGAMN | 461 | Q9BVS4 | |
| EGQMRELQDQLEAEQ | 836 | Q13464 | |
| NREQQEELMRDLAGS | 111 | Q5SXM2 | |
| NFGDVVPRRDFEMQE | 251 | Q2TAA8 | |
| RLTINQREDEDGMAN | 861 | Q5VYS8 | |
| NVAAIREIMEERFGQ | 1156 | Q6N021 | |
| KFMEDEQQLRRQEGQ | 1596 | Q07283 | |
| GFNEMRVILDNEEQR | 186 | Q8IYM9 | |
| TFQDEQRFQLGIMDD | 106 | Q70EL1 | |
| GRQEDEREVAEFMEQ | 5001 | O14686 | |
| MNINDGGRRRFEDNE | 1 | B2RTY4 |